Here are four takeaways:
1. The procedure took place on June 24 and was performed by David Rosenfeld, MD.
2. The intrathecal infusion device was implanted in a 56-year-old female patient suffering from severe chronic pain due to multiple sclerosis.
3. The Prometra II device features a proprietary flow-activated safety valve or FAV technology, which allows patients to safely undergo magnetic resonance imaging.
4. Flowonix Medical is an implantable drug delivery company that received approval by the FDA to market the Prometra device in 2012.
More articles on devices:
Russell indexes add InVivo Therapeutics — 5 key notes
Former OtisMed CEO gets 2 years in prison in knee device scandal — 5 key notes
Amedica shares shoot up 10% — 6 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
